Rothenberg Mace
Tango Therapeutics, Inc. · Director
Rothenberg Mace is listed in public filings as director. This Rothenberg Mace insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Tango Therapeutics, Inc. (TNGX), and Surrozen, Inc. (SRZN). Investors use Rothenberg Mace's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.
Latest Actions
| Company | Holding Value | Last Transaction | Amount | Transaction Price | Current Price |
|---|---|---|---|---|---|
| $506k25k shares | Grant / ExerciseJun 5, 2026 | $505.5K25k shares | $20.22 | -- | |
| --41.5k shares | Grant / ExerciseJun 5, 2026 | Disclosure amount unavailable4k shares | -- | -- |
Insider Trades History
| Company | Holding Value | Last Transaction | Amount | Transaction Price | Current Price |
|---|---|---|---|---|---|
| $167k5.6k shares | Grant / ExerciseMay 13, 2026 | $167.3K5.6k shares | $30.14 | -- | |
| --37.5k shares | Grant / ExerciseJun 5, 2025 | Disclosure amount unavailable6.3k shares | -- | -- | |
| $132k37.5k shares | Grant / ExerciseJun 5, 2025 | $131.6K37.5k shares | $3.51 | -- | |
| $8.7k1.3k shares | Grant / ExerciseMay 14, 2025 | $8.7K1.3k shares | $6.50 | -- | |
| $118k31.3k shares | BuyNov 18, 2024 | $37.8K10k shares | $3.78 | -- | |
| $77k21.3k shares | BuyNov 14, 2024 | $36.2K10k shares | $3.62 | -- |